Phase 4 Limb Ischemia Clinical Trials

3 recruitingPhase 4

What is a Phase 4 trial?

Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.

Showing 1–3 of 3 trials

Recruiting

Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Peripheral Arterial Disease

Peripheral Arterial DiseaseCritical Limb Ischemia

Cell Biopeutics Resources Sdn Bhd10 enrolled1 locationNCT05854641

Recruiting

Phase 4

Efficacy and Safety of Stempeucel® in Patients With Critical Limb Ischemia (CLI) Due to Buerger's Disease

Buerger's DiseaseCritical Limb Ischemia

Cell Biopeutics Resources Sdn Bhd3 enrolled1 locationNCT05854615

Recruiting

Phase 4

The Endovascular Plus GENe Therapy Versus Only EndoVascular Therapy for Severe Limb ischaemiA Trial

Severe Lower Limb Ischemia

Amur State Medical Academy386 enrolled1 locationNCT06473740